Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FtsI, also known as penicillin-binding protein 3 (PBP3), is an essential bacterial cell division protein. It functions as a transpeptidase that catalyzes the cross-linking of peptidoglycan strands in the cell wall at the division septum during cytokinesis. This activity is crucial for maintaining cell shape and integrity during bacterial proliferation. It is inhibited by β-lactam antibiotics.
β-lactam antibiotics inhibit FtsI by irreversibly acylating the active site serine residue, blocking cell wall synthesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial Peptidoglycan Synthase FtsI (FtsI).